fda ruling on tirzepatide update approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA confirms tirzepatide shortage is

Functional signs that your tirzepatide may have degraded Sometimes the first indication is not what you see in the vial but what you feel, or stop feeling, in your body

Keep a simple temperature log near your medication storage area to document your refrigerator's consistency

and a sudden change in the injection site (to unaffected area) has been reported to result in hypoglycemia [see ADVERSE REACTIONS ]

Those with digestive challenges or dietary limitations may also see better results with this approach

Patient Access Network (PAN) Foundation www.panfoundation.org 866-316-7263 Gives help with copayments for patients with insurance